Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ain Shams University | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to assess in vivo the efficacy of Er,Cr:YSGG/diode laser and Diode/EDTA on bacterial count in root canal treatment in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in total bacterial count reduction between conventional irrigation and the two types of lasers used.
Thirty patients are equally divided into 3 separate groups :
The use of lasers in disinfection of the root canal has been recently implemented. Lasers have bactericidal effect, and have deep penetration depth inside the root canal up to 1000 um. Thus, it can be used effectively for disinfection of the root canal system following biomechanical instrumentation reaching areas which were considered before non-reachable.
The aim of this study is to assess in vivo the efficacy of Er,Cr:YSGG/diode laser and Diode/EDTA on root canal treatment in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in total bacterial count reduction between conventional irrigation and the two types of lasers used.
Thirty patients are equally divided into 3 separate groups :
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Conventional group A | Active Comparator |
| |
| Dual laser group B | Experimental |
| |
| Combined group C | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Conventional group (NaOCl/EDTA) | Combination Product | conventional disinfection using 2.5% sodium hypochlorite and 17% EDTA |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quantitative microbiological analysis | aerobic bacterial count will be assessed using colony forming units (CFU) and will be expressed in (CFU/ml). anaerobic bacterial count will be assessed using colony forming units (CFU) and will be expressed in (CFU/ml). | baseline (S1): sample will be obtained before canal disinfection. post operative (S2): sample will be obtained after canal disinfection in a single visit] |
Not provided
Not provided
Inclusion Criteria:
• Patients who are medically free.
Exclusion Criteria:
Patients suffering from any systemic disease.
Patients who had received antibiotics during the last month.
Patients taking analgesics 12 hours before interventions.
Patients with history of tobacco usage
Teeth with vital pulp, calcified canals, and immature or incompletely formed apices.
Teeth with previous endodontic treatment.
Non restorable teeth where rubber dam could not be applied.
Teeth with periodontal pocket more than 3 mm.
Teeth with greater than grade 1 mobility.
Teeth with swelling/sinus tract.
Technical difficulties in the course of root canal treatment for example:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ain Shams University | Cairo | Abbassia | 11566 | Egypt |
Not provided
| ID | Term |
|---|---|
| D003790 | Dental Pulp Necrosis |
| D006099 | Granuloma |
| ID | Term |
|---|---|
| D003788 | Dental Pulp Diseases |
| D014076 | Tooth Diseases |
| D009057 | Stomatognathic Diseases |
| D009336 | Necrosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dual laser group (Er,Cr:YSGG/Diode): | Combination Product | Er,Cr:YSGG intracanal laser irradiation to remove smear layer followed by diode laser for disinfection |
|
| Combined group (EDTA/Diode): | Combination Product | 17% EDTA was used to remove smear layer followed by diode laser for disinfection |
|
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |